TELTEXA CH TRIO
| Dosage: As directed by the Registered Medical Practitioner. |
| Side-effects: Headache, Dizziness, Sleepiness, Edema (swelling), Increased uric acid level in blood, Fatigue, Increased blood lipid level, Increased liver enzymes, Visual disturbance, Breathlessness, Muscle cramp, Gastrointestinal disturbance, Electrolyte imbalance, Increased glucose level in blood, Urticaria, Postural hypotension (low blood pressure), Impotence |
| Contraindications: Contraindicated in patients with known hypersensitivity. |
| Presentation: Available in blister pack of 15 tablets. |
Description
Teltexa CH Trio
Telmisartan 40mg + Chlorthalidone 12.5mg + Amlodipine 5mg
Description:
Teltexa CH Trio is the combination of two blood-pressure lowering medicines: Telmisartan and Metoprolol Succinate.
Indications:
Teltexa CH Trio is used in the treatment of Hypertension (high blood pressure).
Composition:
Teltexa CH Trio
Each film-coated tablet contains :
Chlorthalidone 12.5mg
Amlodipine Besylate IP eq. to Amlodipine 40mg
Telmisartan IP 40mg
Excipients qs
Colours : Ferric oxide USP-NF Yellow & Titanium Dioxide IP
